Notably, the adiponectin receptor (AdipoR) agonist AdipoRon can activate the AMPK/adiponectin/PPAR-α signalling pathway in muscles and liver, thereby counteracting the detrimental effects of obesity [23]. The gene discussed is ADIPOQ; the disease is obesity disorder.